Crossmark

In silico molecular docking studies and MM/GBSA analysis of coumarin-carbonodithioate hybrid derivatives divulge the anticancer potential against breast cancer

Crossref DOI link: https://doi.org/10.1186/s43088-020-00059-7

Published Online: 2020-08-17

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pattar, Shridhar Veeresh

Adhoni, Shakeel Ahamed

Kamanavalli, Chandrappa Mukappa

Kumbar, Suresh Sadashiv
Funding

Funding for this research was provided by:

Department of Science and Technology, Ministry of Science and Technology (SR/PURSE PHASE-2/13(G))
License Information

Text and Data Mining valid from 2020-08-17

Version of Record valid from 2020-08-17
More Information

Article History

Received: 15 January 2020

Accepted: 2 June 2020

First Online: 17 August 2020

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below